These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29650357)

  • 21. Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.
    Pilate T; Verhaegen J; Van Ranst M; Saegeman V
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1741-1747. PubMed ID: 27393490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
    Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
    Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.
    Cioni G; Viale P; Frasson S; Cipollini F; Menichetti F; Petrosillo N; Brunati S; Spigaglia P; Vismara C; Bielli A; Barbanti F; Landini G; Panigada G; Gussoni G; Bonizzoni E; Gesu GP;
    BMC Infect Dis; 2016 Nov; 16(1):656. PubMed ID: 27825317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic and phenotypic diversity of Clostridium difficile during long-term sequential recurrences of infection.
    Sachsenheimer FE; Yang I; Zimmermann O; Wrede C; Müller LV; Gunka K; Groß U; Suerbaum S
    Int J Med Microbiol; 2018 Apr; 308(3):364-377. PubMed ID: 29490877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
    Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
    Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.
    Jin D; Luo Y; Huang C; Cai J; Ye J; Zheng Y; Wang L; Zhao P; Liu A; Fang W; Wang X; Xia S; Jiang J; Tang YW
    J Clin Microbiol; 2017 Mar; 55(3):801-810. PubMed ID: 27974547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile infection (CDI) in children due to hypervirulent strains PCR-ribotype 027: An emblematic report of two cases.
    Spigaglia P; Barbanti F; Castagnola E; Bandettini R
    Anaerobe; 2015 Dec; 36():91-3. PubMed ID: 26385433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
    Seo MR; Kim J; Lee Y; Lim DG; Pai H
    Int J Antimicrob Agents; 2018 May; 51(5):762-767. PubMed ID: 29408226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular typing of Clostridium difficile isolates cultured from patient stool samples and gastroenterological medical devices in a single Iranian hospital.
    Azimirad M; Krutova M; Nyc O; Hasani Z; Afrisham L; Alebouyeh M; Zali MR
    Anaerobe; 2017 Oct; 47():125-128. PubMed ID: 28501554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.
    Jamal W; Rotimi VO; Brazier J; Duerden BI
    Anaerobe; 2010 Dec; 16(6):560-5. PubMed ID: 20887795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular typing and epidemiology of Clostridium difficile in respiratory care wards of central Taiwan.
    Wei HL; Wei SH; Huang CW; Shih CH; Huang YW; Lu MC; Hsu JC; Liou YS; Chiou CS
    J Microbiol Immunol Infect; 2015 Feb; 48(1):65-71. PubMed ID: 23726464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.
    Krutova M; Matejkova J; Drevinek P; Kuijper EJ; Nyc O;
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2251-2258. PubMed ID: 28681203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
    Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
    J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.